dasiglucagon + placebo + GlucaGen HypoKit

Phase 3Completed

0 views this week 0 watching💤 Quiet

Interest: 37/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Hypoglycemia

Conditions

Hypoglycemia

Trial Timeline

Sep 28, 2018 → Jun 28, 2019

NCT ID

NCT03667053

About dasiglucagon + placebo + GlucaGen HypoKit

dasiglucagon + placebo + GlucaGen HypoKit is a phase 3 stage product being developed by Zealand Pharma for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT03667053. Target conditions include Hypoglycemia.

What happened to similar drugs?

2 of 13 similar drugs in Hypoglycemia were approved

Approved (2) Terminated (0) Active (11)

✅Sitagliptin phosphate + PlaceboMerckApproved

✅PramlintideBristol Myers SquibbApproved

🔄Nasal GlucagonEli LillyPhase 3

🔄DasiglucagonNovo NordiskPhase 3

🔄Dasiglucagon + PlaceboZealand PharmaPhase 3

🔄dasiglucagon + GlucaGenZealand PharmaPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03667053	Phase 3	Completed	Sep 28, 2018	Jun 28, 2019	Hypoglycemia

Competing Products

20 competing products in Hypoglycemia

See all competitors

Product	Company	Stage	Hype Score
MBX 1416 (INN imapextide)	MBX Biosciences	Phase 2	36
MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C)	MBX Biosciences	Phase 1	23
Nasal Glucagon	Eli Lilly	Phase 3	40
Glucagon + Insulin	Abvance Therapeutics	Phase 1	19
Nasal Glucagon + Intramuscular Glucagon	Eli Lilly	Phase 1	29
Nasal Glucagon 1 mg + Nasal Glucagon 2 mg + SC Glucagon + Nasal Glucagon 3 mg	Eli Lilly	Phase 2	35
Nasal Glucagon	Eli Lilly	Phase 3	40
Eplerenone + Placebo	Johnson & Johnson	Pre-clinical	26
Sitagliptin phosphate + Placebo	Merck	Approved	43
Pasireotide	Novartis	Phase 1	29
Dasiglucagon	Novo Nordisk	Phase 3	40
Glucagen + Mayne Glucagon	Pfizer	Phase 1	29
Pramlintide	Bristol Myers Squibb	Approved	43
Dasiglucagon + Placebo	Zealand Pharma	Phase 1	26
Dasiglucagon + Dasiglucagon + Placebo	Zealand Pharma	Phase 2	24
ZP4207 + Glucagon	Zealand Pharma	Phase 1	26
ZP4207 + Placebo	Zealand Pharma	Phase 1	26
Dasiglucagon + Placebo	Zealand Pharma	Phase 3	37
dasiglucagon + GlucaGen	Zealand Pharma	Phase 3	37
Dasiglucagon + Placebo	Zealand Pharma	Phase 2	32